Professor
University of California, San Francisco
University of California, San Francisco
Nola Hylton, PhD is Professor of Radiology and Biomedical Imaging at the University of California, San Francisco. She has over 25 years of experience in the areas of medical imaging and breast cancer clinical trials and directs a large NCI-funded program focused on improving quantitative imaging of breast cancer. Dr. Hylton served as PI for ACRIN trials 6657 and 6698, testing dynamic contrast-enhanced (DCE) MRI and diffusion-weighted MRI (DWI) respectively, for assessing breast cancer response to neoadjuvant treatment. She serves as Imaging Chair of the I-SPY 2 TRIAL, a longstanding phase II platform trial of novel agents for breast cancer.
Disclosure information not submitted.
Abbreviated and Ultrafast MRI: Ready for Prime Time vs. CEM
Friday, April 12, 2024
3:15 PM – 4:15 PM